Đang chuẩn bị liên kết để tải về tài liệu:
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Label-retaining cancer cells (LRCC) have been proposed as a model of slowly cycling cancer stem cells (CSC) which mediate resistance to chemotherapy, tumor recurrence, and metastasis. The molecular mechanisms of chemoresistance in LRCC remain to-date incompletely understood. | Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells

TÀI LIỆU LIÊN QUAN

Ebook The difficult hair loss patient - Guide to successful management of alopecia and related conditions: Part 1

Effect of tillage practices on runoff, soil loss, and nutrient loss

Effect of packing and storage conditions on physiological loss in weight, diameter of the flower, electrolyte leakage in extending the vase life of Carnation cv. Kiro

Brain tumor segmentation based on u-net with image driven level set loss

Lệnh bán tự động (Stop loss order)

Understanding Weight Loss Programs: A Teen Eating Disorder Prevention Book

Dynamic effects of dipolar interactions on the specific loss power of Mn0.7Zn0.3Fe2O4

Decreasing induction motor loss using reinforcement learning

Investigation of a hydrogen mitigation system during large break loss of coolant accident for a two-loop pressurized water reactor

Pesticide loss in environment - A review
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.